首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1606520

全球自助醫療器材市場 - 2024-2031

Global Self-care Medical Devices Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球自助醫療器材市場規模達235億美元，預計2031年將達到365億美元，2024-2031年預測期間複合年成長率為5.7%。

自助醫療設備是使人們能夠自行監測和管理健康問題的設備（通常是在家中）。這些設備可讓使用者監測關鍵健康參數，促進主動健康管理和及早發現潛在健康問題，有助於自我保健。自助醫療設備包括多種產品，可以幫助人們檢查自己的健康狀況並治療醫療問題，而無需醫療保健專業人員的持續監督。這些設備以其移動性、方便用戶使用的介面以及快速產生結果的能力而著稱，適合日常使用。

慢性病盛行率的增加是預測期內推動市場的促進因素。例如，根據國際糖尿病聯盟的預測，到 2045 年，IDF 預測顯示，每 8 名成年人中就有 1 人（約 7.83 億人）患有糖尿病，這一數字增加了 46%。超過 90% 的糖尿病患者患有第 2 型糖尿病，這是由社會經濟、人口、環境和遺傳因素所驅動的。由於慢性病數量不斷增加，對用於慢性病管理的醫療器材的需求增加，從而導致預測期內市場的成長。

市場動態：

驅動程式和限制

慢性病盛行率增加

慢性病盛行率的不斷上升預計將成為全球自助醫療器材市場成長的重要因素。慢性病盛行率的上升是全球自助醫療器材市場成長的關鍵驅動力。糖尿病、高血壓、癌症和心血管疾病等慢性疾病需要持續的管理和監測，以避免併發症並改善患者的治療效果。由於人口老化、久坐的生活方式和營養不足等原因，這些疾病變得更加普遍，對能夠讓人們掌控自己健康的自我照護醫療設備的需求也相應增加。

例如，根據美國國立衛生研究院的數據，到 2023 年，美國預計將出現 1,958,310 例新癌症病例和 609,820 例癌症死亡病例。前列腺癌發生率在經歷了二十年的下降之後，從 2014 年到 2019 年每年上升 3%，新增病例增加 99,000 例。年癌症發生率為每 10 萬名男性和女性 440.5 例（基於 2017 年至 2021 年的病例）。每年癌症死亡率（癌症死亡率）為每 10 萬名男性和女性 146.0 人（基於 2018 年至 2022 年的死亡人數）。到 2024 年，預計將有 14,910 名 0 至 19 歲的兒童和青少年被診斷出患有癌症，其中 1,590 人因此死亡。

此外，根據美國國立衛生研究院的數據，約有 4.62 億人患有第 2 型糖尿病，相當於世界人口的 6.28%。例如，根據美國疾病管制與預防中心的數據，大約有 3,840 萬各個年齡層的人（占美國人口的 11.6%）被診斷出患有糖尿病。在18歲及以上的成年人中，這一數字上升至3,810萬，占美國成年人總數的14.7%。由於癌症等慢性病的數量不斷增加，對用於慢性病管理的醫療設備的需求增加，從而導致預測期內市場的成長。

為了為日益流行的慢性病提供解決方案，各組織正在建立策略合作夥伴關係，灌輸最新技術，並推出有助於疾病監測和管理的新產品。例如，2024 年 9 月，先進糖尿病管理解決方案的創新領導者 Beta Bionics 合作，將雅培的葡萄糖感測技術與 iLet Bionic Pancreas 自動化胰島素給藥系統結合。

設備成本高

設備成本高等因素預計將阻礙全球自助醫療設備市場。雖然這些設備有利於管理健康問題和促進預防性護理，但它們的成本仍然是許多潛在用戶的重大障礙。先進的自我照護設備的初始成本可能非常昂貴，特別是對於那些沒有足夠保險的人或低收入群體來說。這種財務負擔可能會阻礙客戶投資這些關鍵技術，從而限制其可及性和廣泛使用。例如，根據《福布斯健康》報道，持續血糖監測平均每月費用為 100 至 300 美元，每年費用為 1,200 至 3,600 美元。

Self-care medical devices are devices that enable people to monitor and manage their health issues on their own accord, usually at home. These devices aid in self-care by allowing users to monitor critical health parameters, promoting proactive health management and early detection of potential health issues. Self-care medical devices include a wide range of products that help people check their health and cure medical issues without the constant supervision of healthcare professionals. These devices are distinguished by their mobility, user-friendly interfaces, and capacity to produce rapid results, making them suitable for everyday use.

The increasing prevalence of chronic diseases is the driving factor that drives the market over the forecast period. For instance, according to the International Diabetes Federation, By 2045, IDF projections show that 1 in 8 adults, approximately 783 million, will be living with diabetes, an increase of 46%. Over 90% of people with diabetes have type 2 diabetes, which is driven by socio-economic, demographic, environmental, and genetic factors. Due to the increasing number of chronic diseases, the demand for medical devices that are used in the management of chronic diseases increases, which results in the growth of the market during the forecast period.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases is expected to be a significant factor in the growth of the global self-care medical devices market. The rising prevalence of chronic diseases is a key driver of growth in the global self-care medical device market. Chronic diseases like diabetes, hypertension, cancer, and cardiovascular ailments necessitate constant management and monitoring to avoid complications and enhance patient outcomes. As these disorders become more widespread as a result of causes such as aging populations, sedentary lifestyles, and insufficient nutrition, there is a corresponding increase in demand for self-care medical devices that allow people to take control of their health.

For instance, according to the National Institute of Health, in 2023, the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths. Prostate cancer incidence climbed by 3% every year from 2014 to 2019, after two decades of reduction, resulting in an additional 99,000 new cases. The annual cancer incidence rate is 440.5 per 100,000 men and women (based on cases from 2017 to 2021). The cancer death rate (cancer mortality) is 146.0 per 100,000 men and women annually (based on deaths from 2018-2022). In 2024, a projected 14,910 children and adolescents between the ages of 0 and 19 will be diagnosed with cancer, with 1,590 deaths from the condition.

Moreover, according to the National Institute of Health, approximately 462 million individuals were affected by type 2 diabetes corresponding to 6.28% of the world's population. For instance, according to the Centers for Disease Control and Prevention, approximately 38.4 million individuals of all ages, representing 11.6% of the U.S. population, were diagnosed with diabetes. Among adults aged 18 and older, this figure rose to 38.1 million, accounting for 14.7% of all U.S. adults. Due to the increasing number of chronic diseases like cancer, the demand for medical devices that are used in the management of chronic diseases increases, which results in the growth of the market during the forecast period.

In order to offer solutions for the increasing prevalence of chronic diseases, organizations are entering into strategic partnerships, inculcating the latest technology, and launching new products that help in disease monitoring and management. For instance, in September 2024, Beta Bionics, an innovative leader in advanced diabetes management solutions, collaborated to combine Abbott's glucose sensing technology with the iLet Bionic Pancreas automated insulin administration system.

High Costs of Devices

Factors such as the high costs of devices are expected to hamper the global self-care medical devices market. While these devices are beneficial for managing health issues and promoting preventative care, their cost remains a significant barrier for many potential users. The initial cost of advanced self-care gadgets might be prohibitively expensive, especially for those without adequate insurance coverage or in lower-income groups. This financial burden may discourage customers from investing in these critical technologies, limiting their accessibility and widespread use. For instance, according to Forbes Health, continuous glucose monitoring costs average $100 to $300 a month, which is $1,200 to $3,600 annually.

Segment Analysis

The global self-care medical devices market is segmented based on product type, technology, distribution channel and region.

Blood glucose monitors segment is expected to dominate the global self-care medical devices market share

The blood glucose monitors segment is expected to dominate the global self-care medical devices market due to a number of compelling factors, including the growing demand for improved diabetes control. Diabetes is becoming a more common health condition around the world, thus there is a greater need for dependable and user-friendly monitoring systems. Blood glucose monitors, which include both classic self-monitoring devices and advanced continuous glucose monitoring systems, are critical tools for patients managing their disease. Patients can use these devices to conveniently and accurately track their blood sugar levels, enabling timely adjustments to their treatment plans.

The increasing prevalence of diabetes is one of the major reasons making blood glucose monitors the dominant segment. Due to the increasing prevalence of diabetes, the demand for devices used for monitoring and management of diabetes increases making blood glucose monitors the dominating segment. For instance, according to the Centers for Disease Control and Prevention, in 2021, approximately 38.4 million individuals of all ages, representing 11.6% of the U.S. population, were diagnosed with diabetes. Among adults aged 18 and older, this figure rose to 38.1 million, accounting for 14.7% of all U.S. adults.

In recent times, there have been new launches that use the latest technology, acquisitions, and partnerships in this segment making it the most dominating one. For instance, in November 2024, Oura announced a strategic partnership with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which tracks sleep, heart rate, and activity. Oura was granted a $75 million fund from Dexcom in a series D funding round, valuing the company at more than $5 billion.

Geographical Analysis

North America is expected to hold a significant position in the global self-care medical devices market share

North America is expected to hold a significant portion of the global self-care medical devices market. North America is expected to maintain the dominant position in the worldwide self-care medical devices market, owing to a number of variables that improve the region's healthcare landscape. The key reason for this supremacy is the presence of a highly developed healthcare infrastructure, which includes advanced medical facilities a strong supply chain for medicinal items, and an increasing prevalence of chronic diseases. This infrastructure enables the easy adoption of self-care medical devices, giving customers access to a diverse selection of goods geared for personal health management. The region's commitment to medical innovation and technology helps to support the incorporation of these technologies into routine healthcare procedures.

The rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer is fuelling the need for IVDs in North America. For instance, according to the CDC, approximately 38.4 million individuals of all ages, representing 11.6% of the U.S. population, were diagnosed with diabetes. Among adults aged 18 and older, this figure rose to 38.1 million, accounting for 14.7% of all U.S. adults.

In this region, there are recent launches, acquisitions, and strategic partnerships in the self-care medical devices market making this region hold the highest market share. For instance, in June 2024, Prevounce Health, a prominent provider of remote care management software, devices, and services, announced the introduction of their first remote blood glucose monitoring device, Pylo GL1-LTE. The blood glucose meter is scientifically verified and links to various cellular networks to provide dependable data transmission across the United States. The GL1-LTE is compatible with the Prevounce remote care management platform and can interface with other health software through the Pylo cloud API. Prevounce's range of Pylo cellular-connected products encompasses blood pressure monitors and weight scales.

Asia Pacific is growing at the fastest pace in the global self-care medical devices market

Asia Pacific is experiencing the fastest growth in global self-care medical devices owing to the increasing incidence of chronic diseases and technological advancements in the region. For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively. Due to the increasing number of chronic diseases like cancer, the demand for monitoring and management devices is increasing in this region, making it the most significant region in this market.

Competitive Landscape

The major global players in the global self-care medical devices market include Johnson & Johnson Services, Inc., Medtronic, Abbott, Bayer, Koninklijke Philips N.V., GE HealthCare, F. Hoffmann-La Roche Ltd, ResMed, OMRON Healthcare, Baxter among others.

Emerging Players

Genomtec, QuantiLight, and GeneSys Bio among others

Key Developments

In November 2023, DuPont announced that DuPon Liveo Healthcare Solutions is collaborating with STMicroelectronics, a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal monitoring.
In August 2024, Prevounce Health, announced the launch of its first blood oxygen device for remote patient monitoring (RPM) Pylo OX1-LTE. The clinically validated, cellular-connected OX1-LTE offers numerous advantages over other pulse oximeters for patients enrolled in RPM programs for chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, and a variety of other scenarios.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global self-care medical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Distribution Channel
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Blood Glucose Monitors*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Blood Pressure Monitors
6.4. Body Temperature Monitors
6.5. Pulse Oximeters
6.6. Inhalers and Nebulizers
6.7. Fitness Monitoring Trackers

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Miniaturization Technologies*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Artificial Intelligence (AI)
7.4. Bluetooth and Wireless Connectivity
7.5. Telehealth Integration

8. By Distribution Channel

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Hospital Pharmacies*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Retail Pharmacies
8.4. Online Pharmacies

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Johnson & Johnson Services, Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medtronic
11.3. Abbott
11.4. Bayer
11.5. Koninklijke Philips N.V.
11.6. GE HealthCare
11.7. F. Hoffmann-La Roche Ltd
11.8. ResMed
11.9. OMRON Healthcare
11.10. Baxter

LIST NOT EXHAUSTIVE